Maolac no longer wants to be thought of as âthe colostrum companyâ, but a biotech championing biofunctional proteins from both animal and non-animal sources, CEO Maya Ashkenazi explains.
Maolac 2.0: Start-up looks to fungi and plant side streams for breast milk protein biosimilarity
By 
Add A Comment